Studija slučaja
https://doi.org/10.21857/ygjwrcp78y
Repeated intravenous thrombolytic therapy with rt-PA alteplase in treatment of early recurrent ischemic stroke
Josip Sekovanić
Sara Drnasin
Mislav Budišić
Lidija Dežmalj Grbelja
Marijana Bosnar Purerić
Marina Roje Bedeković
Sažetak
The 2019 year guidelines (American Heart Association / American Stroke Association – AHA/ASA) do not recommend treating recurrent acute ischemic stroke with alteplase in patients who had previ- ous stroke in last 3 months (1,9). According to the European Stroke Organisation`s (ESO) guidelines (year 2021), there is no clear consensus. The risk of reocclusion occurs in 14-34% of patients in whom recanalisation with alteplase has been achieved (1). In this paper we present the case of our 70-year old patient with early stroke recurrence and repeated thrombolytic therapy 9 hours after the first dose of alteplase.
Ključne riječi
repeated thrombolytic therapy; early recurrent ischemic stroke; intravenous thrombolysis; recombinant tissue plasminogen activator; rt-PA; alteplase
Hrčak ID:
308345
URI
Datum izdavanja:
25.6.2023.
Posjeta: 192 *